Merit Medical Systems Inc (MMSI) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Merit Medical Systems Inc stock (MMSI) is currently trading at $68.11. Merit Medical Systems Inc PE ratio is 31.71. Merit Medical Systems Inc PS ratio (Price-to-Sales) is 2.65. Analyst consensus price target for MMSI is $102.00. WallStSmart rates MMSI as Hold.
- MMSI PE ratio analysis and historical PE chart
- MMSI PS ratio (Price-to-Sales) history and trend
- MMSI intrinsic value — DCF, Graham Number, EPV models
- MMSI stock price prediction 2025 2026 2027 2028 2029 2030
- MMSI fair value vs current price
- MMSI insider transactions and insider buying
- Is MMSI undervalued or overvalued?
- Merit Medical Systems Inc financial analysis — revenue, earnings, cash flow
- MMSI Piotroski F-Score and Altman Z-Score
- MMSI analyst price target and Smart Rating
Merit Medical Systems Inc
📊 No data available
Try selecting a different time range
MMSI Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Merit Medical Systems Inc (MMSI)
MMSI appears undervalued based on the Graham Formula, trading 18% below its estimated fair value of $99.68.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Merit Medical Systems Inc (MMSI) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, eps growth, institutional own.. Concerns around return on equity. Fundamentals are solid but monitor weak areas for improvement.
Merit Medical Systems Inc (MMSI) Key Strengths (4)
Earnings per share surging 38.80% year-over-year
107.37% of shares held by major funds and institutions
Good growth relative to its price
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Merit Medical Systems Inc (MMSI) Areas to Watch (6)
Low profitability relative to shareholder equity
Thin profit margins with limited profitability
Decent operational efficiency, solid but not exceptional
Revenue is fairly priced at 2.65x sales
Fairly priced relative to book value
Solid revenue growth at 10.90% per year
Supporting Valuation Data
Merit Medical Systems Inc (MMSI) Detailed Analysis Report
Overall Assessment
This company scores 65/100 in our Smart Analysis, earning a C+ grade. Out of 10 metrics analyzed, 4 register as strengths (avg 8.8/10) while 6 fall into concern territory (avg 5.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on EPS Growth, Institutional Own., PEG Ratio. Valuation metrics including PEG Ratio (1.37) suggest the stock is attractively priced. Growth metrics are encouraging with EPS Growth at 38.80%.
The Bear Case
The primary concerns are Return on Equity, Profit Margin, Operating Margin. Some valuation metrics including Price/Sales (2.65), Price/Book (2.50) suggest expensive pricing. Growth concerns include Revenue Growth at 10.90%, which may limit upside. Profitability pressure is visible in Return on Equity at 8.67%, Operating Margin at 15.80%, Profit Margin at 8.48%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 8.67% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 10.90% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (EPS Growth, Institutional Own.) and negatives (Return on Equity, Profit Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
MMSI Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
MMSI's Price-to-Sales ratio of 2.65x sits near its historical average of 2.44x (61th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 44% below its historical high of 4.76x set in Jan 2025, and 160% above its historical low of 1.02x in Apr 2013. Over the past 12 months, the PS ratio has compressed from ~4.5x as trailing revenue scaled faster than the stock price.
Compare MMSI with Competitors
Top MEDICAL INSTRUMENTS & SUPPLIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Merit Medical Systems Inc (MMSI) · HEALTHCARE › MEDICAL INSTRUMENTS & SUPPLIES
The Big Picture
Merit Medical Systems Inc operates as a stable business with moderate growth and solid fundamentals. Revenue reached 1.5B with 11% growth year-over-year. Profit margins are thin at 8.5%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
Generating 77M in free cash flow and 99M in operating cash flow. Earnings are translating into actual cash generation.
What to Watch Next
Margin expansion: can Merit Medical Systems Inc push profit margins above 15% as the business scales?
Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact Merit Medical Systems Inc.
Bottom Line
Merit Medical Systems Inc offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Merit Medical Systems Inc(MMSI)
NASDAQ
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
USA
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, intensive care, and endoscopy. The company is headquartered in South Jordan, Utah.